1. Home
  2. CFFN vs MPLT Comparison

CFFN vs MPLT Comparison

Compare CFFN & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$7.79

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$30.19

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CFFN
MPLT
Founded
1893
2018
Country
United States
United States
Employees
N/A
133
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
1.2B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
CFFN
MPLT
Price
$7.79
$30.19
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$7.25
$32.67
AVG Volume (30 Days)
858.4K
275.5K
Earning Date
04-29-2026
05-28-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
N/A
Revenue This Year
$20.16
N/A
Revenue Next Year
$6.62
N/A
P/E Ratio
$24.25
N/A
Revenue Growth
6.54
N/A
52 Week Low
$5.51
$12.24
52 Week High
$7.97
$33.28

Technical Indicators

Market Signals
Indicator
CFFN
MPLT
Relative Strength Index (RSI) 56.60 56.53
Support Level $7.47 $26.70
Resistance Level $7.84 $32.68
Average True Range (ATR) 0.17 2.80
MACD -0.01 -0.50
Stochastic Oscillator 60.22 49.93

Price Performance

Historical Comparison
CFFN
MPLT

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: